Delivery Order SPE2DB20D3103-SPE2DB23FL4J1
- Not listed
- This federal contract award, valued at $11,271.08, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Amoxicillin-Clavulanate 1,000-62.5 mg tablets, a pharmaceutical product used to treat bacterial infections. The contract has an ultimate completion date of September 19, 2023 and is structured as a firm fixed-price delivery order. The contract was awarded on an unrestricted basis, with no set-aside...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,741.31, is for the delivery of Amoxicillin-Clavulanate 250-125 mg tablets. The contract is a firm fixed-price delivery order with an ultimate completion date of April 27, 2023. This award is part of AmerisourceBergen's larger Indefinite Delivery Contract...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Amoxicillin-Clavulanate 250-125 mg tablets, with a ceiling value of $1,236.05 and a performance period through December 16, 2024. This award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Amoxicillin-Clavulanate 875-125 mg tablets. The $1,901.28 firm-fixed-price delivery order has a period of performance through May 2, 2023. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that supplies a wide range of medical products to various federal agencies,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,352.38 delivery order contract is for the supply of Amoxicillin-Clavulanate Potassium 1,000-62.5 mg Tablets. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical. This single-award IDC...
- This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of Amoxicillin-Clavulanate 875-125 mg tablets. The $1,984.50 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,661.60 firm-fixed-price delivery order is for the supply of Amoxicillin-Clavulanate 500-125 mg tablets to support military healthcare programs. The award is not designated as a set-aside contract. It is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc.,...
- This federal contract award, valued at $3,897.75, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Amoxicillin-Clavulanate 875-125 mg tablets, a common antibiotic medication. The contract is a firm-fixed-price delivery order, with a period of performance ending on September 17, 2024. There is no set-aside designation for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $2,378.66, is for the delivery of Amoxicillin-Clavulanate 1,000-62.5 mg tablets to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 27, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at up to $1,751.50, is for the delivery of Amoxicillin/Clavulana, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type, with a performance period ending on May 7, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, was awarded this contract without...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FL4J1Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,196.66 firm fixed-price delivery order is for the supply of Amoxicillin-Clavulanate 250-125 mg tablets, a commonly prescribed antibiotic medication. The contract has an ultimate completion date of October 26, 2022 and was awarded on October 25, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. (the parent company of Amerisourcebergen Drug Corp) holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract award does not have a set-aside designation, indicating it was competed on an unrestricted basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 10/25/22 |